A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients

NCT03344653 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2000

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Medtronic Resolute Onyx Zotarolimus-Eluting Coronary Stent System
DEVICE: Biosensors BioFreedom BA9 Drug Coated Coronary Stent

Sponsor

Medtronic Vascular